This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN et al. Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. Biol Blood Marrow Transplant 2008; 14: 236–245.
Bloor AJ, Thomson K, Chowdhry N, Verfuerth S, Ings SJ, Chakraverty R et al. High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2008; 14: 50–58.
Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R et al. Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy. Cancer 2008; 112: 2228–2232.
VanderMolen LA, Steis RG, Duffey PL, Foon KA, Smith 2nd JW, Clark JW et al. Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma. J Natl Cancer Inst 1990; 82: 235–238.
Mantovani L, Guglielmi C, Martelli M, Chierichini A, Deriu L, Sertoli MR et al. Recombinant alpha interferon in the treatment of low-grade non-Hodgkin's lymphoma: results of a cooperative phase II trial in 31 patients. Haematologica 1989; 74: 571–575.
Rohatiner AZ, Gregory WM, Peterson B, Borden E, Solal-Celigny P, Hagenbeek A et al. Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol 2005; 23: 2215–2223.
Grigg A, Kannan K, Schwarer AP, Spencer A, Szer J . Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation. Intern Med J 2001; 31: 15–22.
Tatsugami K, Eto M, Naito S . Influence of immunotherapy with interferon-alpha on regulatory T cells in renal cell carcinoma patients. J Interferon Cytokine Res 2010; 30: 43–48.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Arima, N., Yoshinaga, N., Maruyama, W. et al. Rapid response to IFN-α in a patient with relapsed follicular lymphoma after cord blood transplantation. Bone Marrow Transplant 46, 448–449 (2011). https://doi.org/10.1038/bmt.2010.104
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.104